Oryzon Genomics Valuation
| ORYZF Stock | USD 3.60 0.00 0.00% |
At this time, the company appears to be fairly valued. Oryzon Genomics SA holds a recent Real Value of $3.54 per share. The prevailing price of the company is $3.6. Our model determines the value of Oryzon Genomics SA from analyzing the company fundamentals such as Operating Margin of (0.72) %, shares outstanding of 55.26 M, and Return On Equity of -0.0685 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Oryzon Genomics' price fluctuation is somewhat reliable at this time. Calculation of the real value of Oryzon Genomics SA is based on 3 months time horizon. Increasing Oryzon Genomics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Oryzon pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Oryzon Genomics SA. Since Oryzon Genomics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Oryzon Pink Sheet. However, Oryzon Genomics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.6 | Real 3.54 | Hype 3.6 |
The real value of Oryzon Pink Sheet, also known as its intrinsic value, is the underlying worth of Oryzon Genomics SA Company, which is reflected in its stock price. It is based on Oryzon Genomics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Oryzon Genomics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Oryzon Genomics SA helps investors to forecast how Oryzon pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Oryzon Genomics more accurately as focusing exclusively on Oryzon Genomics' fundamentals will not take into account other important factors: About Oryzon Genomics Valuation
The pink sheet valuation mechanism determines Oryzon Genomics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Oryzon Genomics. We calculate exposure to Oryzon Genomics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Oryzon Genomics's related companies.Oryzon Genomics S.A., a clinical phase biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders. The company was founded in 2000 and is based in Cornell de Llobregat, Spain. Oryzon Genomics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 43 people.
8 Steps to conduct Oryzon Genomics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Oryzon Genomics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Oryzon Genomics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Oryzon Genomics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Oryzon Genomics' revenue streams: Identify Oryzon Genomics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Oryzon Genomics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Oryzon Genomics' growth potential: Evaluate Oryzon Genomics' management, business model, and growth potential.
- Determine Oryzon Genomics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Oryzon Genomics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Oryzon Genomics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Oryzon Genomics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 52.8 M | |
| Quarterly Earnings Growth Y O Y | -0.717 | |
| Retained Earnings | -8 M |
Complementary Tools for Oryzon Pink Sheet analysis
When running Oryzon Genomics' price analysis, check to measure Oryzon Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oryzon Genomics is operating at the current time. Most of Oryzon Genomics' value examination focuses on studying past and present price action to predict the probability of Oryzon Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oryzon Genomics' price. Additionally, you may evaluate how the addition of Oryzon Genomics to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |